MWG Caph Ltd

In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), MWG Caph Ltd reported 3 stock positions worth $72.4 million. Its top holding was Beam Therapeutics (BEAM) at 48.5% of the portfolio, followed by Lyell Immunopharma (LYEL, 42.9%) and Prime Medicine (PRME, 8.6%).

Most Recent 13F
Q4 2025
Location
WASHINGTON, DC
CIK
0002111120
Portfolio Value
$72.4M (Q4 2025)
SEC Filing
0001193125-26-053978 ↗ filed Feb 17, 2026

Holdings 3 stocks · $72.4M
BEAM Beam Therapeutics Inc. 48.53% 1,266,934 $35.1M —
LYEL Lyell Immunopharma Inc. 42.88% 1,008,116 $31.0M —
PRME Prime Medicine Inc. 8.59% 1,792,210 $6.2M —

Portfolio Sells Q4 2025

No earlier filing to compare with.

Portfolio Buys Q4 2025

No earlier filing to compare with.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 3$72.4MBEAM, LYEL, PRME